PolyPeptide
PPGN.SWPolyPeptide Group Price (PPGN.SW)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
32,987,924
(0.0604)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
PolyPeptide Group AGCurrency: CHF
| YEAR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
179,574,000.00
+0% |
202,613,000.00
+13% |
224,296,000.00
+11% |
282,126,000.00
+26% |
280,978,000.00
0% |
320,372,000.00
+14% |
338,688,000.00
+6% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 117,450,000.00 | 131,039,000.00 | 151,108,000.00 | 182,426,000.00 | 228,987,000.00 | 315,599,000.00 | 299,422,000.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
62,124,000.00
+0% |
71,574,000.00
+15% |
73,188,000.00
+2% |
99,700,000.00
+36% |
51,991,000.00
-48% |
4,773,000.00
-91% |
39,266,000.00
+723% |
||||||||||||
| Gross Profit Ratio | (0.35%) | (0.35%) | (0.33%) | (0.35%) | (0.19%) | (0.01%) | (0.12%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 12,307,000.00 | 14,375,000.00 | 1,312,000.00 | 1,407,000.00 | 1,243,000.00 | 1,465,000.00 | 1,095,000.00 | ||||||||||||
| General and Administrative | 8,675,000.00 | 9,069,000.00 | 23,758,000.00 | 27,577,000.00 | 34,543,000.00 | 17,181,000.00 | 20,147,000.00 | ||||||||||||
| Selling, General & Admin... | 9,989,000.00 | 10,306,000.00 | 28,013,000.00 | 32,497,999.00 | 40,627,000.00 | 18,760,000.00 | 21,330,000.00 | ||||||||||||
| Selling & Marketing Exp... | 1,314,000.00 | 1,237,000.00 | 3,640,000.00 | 3,864,000.00 | 4,905,000.00 | 1,579,000.00 | 1,183,000.00 | ||||||||||||
| Depreciation and Amortiz... | 14,422,000.00 | 15,808,000.00 | 17,545,000.00 | 20,683,000.00 | 26,063,000.00 | 30,469,000.00 | 32,714,000.00 | ||||||||||||
| Other Expenses | 12,068,000.00 | 13,344,000.00 | 0.00 | 0.00 | 0.00 | 20,885,000.00 | 24,205,000.00 | ||||||||||||
| Total Operating Expenses | 34,364,000.00 | 38,025,000.00 | 32,293,999.00 | 37,037,000.00 | 42,342,000.00 | 41,110,000.00 | 46,630,000.00 | ||||||||||||
| Cost and Exponses | 151,814,000.00 | 169,064,000.00 | 183,401,999.00 | 219,463,000.00 | 271,329,000.00 | 356,840,000.00 | 346,052,000.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
27,760,000.00
+0% |
33,549,000.00
+21% |
44,311,000.00
+32% |
67,401,000.00
+52% |
12,527,000.00
-81% |
-36,468,000.00
-391% |
-7,364,000.00
-80% |
||||||||||||
| Operating Income Ratio | (0.15%) | (0.17%) | (0.20%) | (0.24%) | (0.04%) | (-0.11%) | (-0.02%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 78,000.00 | 70,000.00 | 3,209,000.00 | 2,815,000.00 | 2,081,999.00 | 54,000.00 | 586,000.00 | ||||||||||||
| Interest Expenses | 4,117,000.00 | 3,243,000.00 | 3,315,000.00 | 2,823,000.00 | 2,091,000.00 | 5,623,000.00 | 13,848,000.00 | ||||||||||||
| Total Other Income/Exp... | 1,694,000.00 | -3,316,000.00 | -6,693,000.00 | -4,317,000.00 | -5,040,000.00 | -21,775,000.00 | -10,781,000.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 42,586,000.00 | 49,284,000.00 | 58,545,000.00 | 83,354,000.00 | 35,721,000.00 | -22,151,000.00 | 28,417,000.00 | ||||||||||||
| EBITDA ratio | (0.24%) | (0.24%) | (0.26%) | (0.30%) | (0.12%) | (-0.07%) | (0.08%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 29,454,000.00 | 30,233,000.00 | 37,685,000.00 | 59,848,000.00 | 7,567,000.00 | -58,243,000.00 | -18,145,000.00 | ||||||||||||
| Income Before Tax Ratio | (0.16%) | (0.15%) | (0.17%) | (0.21%) | (0.03%) | (-0.18%) | (-0.05%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 5,634,000.00 | 4,496,000.00 | 6,350,000.00 | 12,590,000.00 | 200,000.00 | -6,803,000.00 | 1,419,000.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 23,820,000.00
+0% |
25,737,000.00
+8% |
31,335,000.00
+22% |
47,258,000.00
+51% |
7,767,000.00
-84% |
-51,440,000.00
-762% |
-19,564,000.00
-62% |
||||||||||||
| Net Income Ratio | (0.13%) | (0.13%) | (0.14%) | (0.17%) | (0.03%) | (-0.16%) | (-0.06%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.79 | 0.86 | 1.04 | 1.47 | 0.24 | -1.56 | -0.59 | ||||||||||||
| Diluted EPS | 0.79 | 0.86 | 1.04 | 1.47 | 0.24 | -1.56 | -0.59 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 30,000,000.00 | 30,000,000.00 | 30,000,000.00 | 32,097,000.00 | 32,986,000.00 | 32,941,000.00 | 32,933,948.00 | ||||||||||||
| Diluted Share Outstanding | 30,000,000.00 | 30,000,000.00 | 30,000,000.00 | 32,124,000.00 | 33,003,999.00 | 32,968,000.00 | 32,987,924.00 | ||||||||||||